Medicyte and PRIMACYT Receive 300k Euro Grant to Develop Human Liver Cells for Cell-based Therapies
Published: Monday, March 05, 2012 Last Updated: Monday, March 05, 2012
Cell-based therapies and the development of transplantable bioartificial livers to treat severe liver diseases still fail due to the limited availability of appropriate cells in large numbers and clinical quality. These failures are often related to the complex and difficult culturing of liver cells.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.